Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature
JV Juturi B Francis PW Chintz Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature Dis Colon Rectum 42 1999 102 109
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
MJ O'Connell JA Martenson HS Wieand Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502 507
Stem cell carcinoma of the colon and rectum. Report of two cases and review of the literature
DH Palvio FB Sorensen M Klove-Mogensen Stem cell carcinoma of the colon and rectum. Report of two cases and review of the literature Dis Colon Rectum 28 1985 440 445
Squamous-cell carcinoma of the colon. Experience at the University of Chicago, review of the literature, report of two cases
F Michelassi LA Mishlove F Stipa Squamous-cell carcinoma of the colon. Experience at the University of Chicago, review of the literature, report of two cases Dis Colon Rectum 31 1988 228 235
Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma
K Ikeda M Terashima K Ishida Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma Gan To Kagaku Ryoho 15 1988 677 682
Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma
J Niklinski M Furman J Laudanski Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma Neoplasma 39 1992 279 282
Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months
B Clasen D Roettger R Senekowitsch Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months Laryngol Rhinol Otol (Stuttg) 67 1988 420 425